The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPureTech Regulatory News (PRTC)

Share Price Information for PureTech (PRTC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 227.50
Bid: 226.50
Ask: 228.00
Change: 2.00 (0.89%)
Spread: 1.50 (0.662%)
Open: 228.00
High: 228.50
Low: 224.50
Prev. Close: 225.50
PRTC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

11 Dec 2023 07:00

RNS Number : 2496W
PureTech Health PLC
11 December 2023
 

11 December 2023

 

PureTech Health plc

 

Transaction in Own Shares

 

PureTech Health PLC (the "Company") announces that it has purchased the following number of its ordinary shares of one pence each through Jefferies International Limited ("Jefferies"), as part of its Share Buyback Programme, details of which were announced on 9 May 2022.

 

Date of purchase:

08 December 2023

Number of ordinary shares purchased:

57,808

Highest price paid per share:

143.00p

Lowest price paid per share:

140.40p

Volume weighted average price paid per share:

141.79p

 

PureTech intends to retain the purchased shares in treasury.

Following the above transaction, the Company will have 17,063,635 ordinary shares in treasury and has 272,404,524 ordinary shares in issue (excluding treasury shares). The total number of voting rights in the Company is therefore 272,404,524 which may be used by shareholders in their calculations to determine if they are required to notify their interest in, or a change to their interest in, PureTech Health plc under the FCA's Disclosure Guidance and Transparency Rules.

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) (the Market Abuse Regulation), detailed information about the individual purchases is available below.

 

About PureTech Health

PureTech is a clinical-stage biotherapeutics company dedicated to giving life to new classes of medicine to change the lives of patients with devastating diseases. The Company has created a broad and deep pipeline through its experienced research and development team and its extensive network of scientists, clinicians and industry leaders that is being advanced both internally and through its Founded Entities. PureTech's R&D engine has resulted in the development of 27 therapeutics and therapeutic candidates, including two (Plenity® and EndeavorRx®) that have received both U.S. FDA clearance and European marketing authorization and a third (KarXT) that has been filed for FDA approval. A number of these programs are being advanced by PureTech or its Founded Entities in various indications and stages of clinical development, including registration enabling studies. All of the underlying programs and platforms that resulted in this pipeline of therapeutic candidates were initially identified or discovered and then advanced by the PureTech team through key validation points.

 

For more information, visit www.puretechhealth.com or connect with us on X, formerly known as Twitter, @puretechh.

 

Contact:

PureTech

Investor Relations

IR@puretechhealth.com

Individual Transactions

 

Transaction Date

Transaction Time

Volume

Price (GBp)

Platform

Transaction Reference Number

08/12/2023

09:30:14

249

142.4

AQXE

00381556432TRLO0.1.1

08/12/2023

09:30:14

249

142.4

AQXE

00381556433TRLO0.1.1

08/12/2023

09:30:14

387

142.4

BATE

00381556434TRLO0.1.1

08/12/2023

09:30:14

387

142.4

BATE

00381556435TRLO0.1.1

08/12/2023

09:30:14

387

142.4

CHIX

00381556436TRLO0.1.1

08/12/2023

09:30:14

139

142.4

TRQX

00381556437TRLO0.1.1

08/12/2023

09:30:14

139

142.4

TRQX

00381556438TRLO0.1.1

08/12/2023

09:30:14

1161

142.4

XLON

00381556439TRLO0.1.1

08/12/2023

09:30:14

699

142.4

XLON

00381556440TRLO0.1.1

08/12/2023

09:31:06

15

141.2

CHIX

00381556541TRLO0.1.1

08/12/2023

09:31:08

372

141.2

CHIX

00381556550TRLO0.1.1

08/12/2023

09:31:08

385

141.2

XLON

00381556551TRLO0.1.1

08/12/2023

09:31:08

776

141.2

XLON

00381556552TRLO0.1.1

08/12/2023

10:57:40

559

142.8

XLON

00381569766TRLO0.1.1

08/12/2023

11:43:39

559

142.8

XLON

00381575865TRLO0.1.1

08/12/2023

11:43:42

2944

143

XLON

00381575868TRLO0.1.1

08/12/2023

11:43:42

4914

143

XLON

00381575869TRLO0.1.1

08/12/2023

11:46:37

387

143

XLON

00381576186TRLO0.1.1

08/12/2023

11:47:00

387

142

CHIX

00381576246TRLO0.1.1

08/12/2023

11:47:00

274

142

XLON

00381576248TRLO0.1.1

08/12/2023

11:47:00

61

142

XLON

00381576249TRLO0.1.1

08/12/2023

11:47:00

647

142

XLON

00381576250TRLO0.1.1

08/12/2023

11:47:00

566

142

XLON

00381576251TRLO0.1.1

08/12/2023

11:47:01

387

141.8

BATE

00381576254TRLO0.1.1

08/12/2023

11:47:01

249

141.8

AQXE

00381576253TRLO0.1.1

08/12/2023

11:47:06

139

141.4

TRQX

00381576261TRLO0.1.1

08/12/2023

11:47:08

560

141.8

CHIX

00381576263TRLO0.1.1

08/12/2023

12:03:31

387

140.8

CHIX

00381577770TRLO0.1.1

08/12/2023

12:03:31

387

140.8

XLON

00381577771TRLO0.1.1

08/12/2023

12:03:31

111

140.8

XLON

00381577772TRLO0.1.1

08/12/2023

12:03:31

387

140.6

BATE

00381577773TRLO0.1.1

08/12/2023

12:11:11

49

140.4

CHIX

00381578562TRLO0.1.1

08/12/2023

12:11:11

101

140.6

CHIX

00381578563TRLO0.1.1

08/12/2023

12:11:34

95

140.4

CHIX

00381578599TRLO0.1.1

08/12/2023

12:12:28

62

140.4

CHIX

00381578693TRLO0.1.1

08/12/2023

12:13:06

63

140.4

CHIX

00381578751TRLO0.1.1

08/12/2023

12:13:52

69

140.4

CHIX

00381578832TRLO0.1.1

08/12/2023

12:43:03

663

140.6

XLON

00381581709TRLO0.1.1

08/12/2023

13:34:18

249

140.8

AQXE

00381589653TRLO0.1.1

08/12/2023

13:34:18

387

140.6

CHIX

00381589654TRLO0.1.1

08/12/2023

13:34:18

387

140.6

BATE

00381589655TRLO0.1.1

08/12/2023

13:34:18

1548

140.6

XLON

00381589656TRLO0.1.1

08/12/2023

13:35:07

387

140.4

CHIX

00381589951TRLO0.1.1

08/12/2023

13:40:42

297

141.6

CHIX

00381591280TRLO0.1.1

08/12/2023

13:40:42

46

141.6

CHIX

00381591281TRLO0.1.1

08/12/2023

14:37:22

387

141.4

CHIX

00381605540TRLO0.1.1

08/12/2023

14:37:22

476

141.4

XLON

00381605541TRLO0.1.1

08/12/2023

14:37:22

72

141.4

XLON

00381605549TRLO0.1.1

08/12/2023

14:37:22

1000

141.4

XLON

00381605548TRLO0.1.1

08/12/2023

14:37:22

737

141.4

XLON

00381605550TRLO0.1.1

08/12/2023

14:37:22

249

141.2

AQXE

00381605551TRLO0.1.1

08/12/2023

14:37:22

15

141

TRQX

00381605553TRLO0.1.1

08/12/2023

14:37:22

90

141

TRQX

00381605552TRLO0.1.1

08/12/2023

14:37:22

18

141

TRQX

00381605554TRLO0.1.1

08/12/2023

14:37:22

139

141

TRQX

00381605555TRLO0.1.1

08/12/2023

14:37:22

16

141

TRQX

00381605556TRLO0.1.1

08/12/2023

14:37:22

790

141.4

CHIX

00381605557TRLO0.1.1

08/12/2023

14:37:22

210

141.4

CHIX

00381605558TRLO0.1.1

08/12/2023

14:37:22

210

141.4

CHIX

00381605559TRLO0.1.1

08/12/2023

14:37:22

790

141.4

CHIX

00381605560TRLO0.1.1

08/12/2023

14:37:22

387

141

BATE

00381605561TRLO0.1.1

08/12/2023

14:37:22

387

141

BATE

00381605563TRLO0.1.1

08/12/2023

14:41:24

1302

141.8

CHIX

00381608047TRLO0.1.1

08/12/2023

15:20:40

774

141.4

CHIX

00381631327TRLO0.1.1

08/12/2023

15:21:59

59

142

BATE

00381631855TRLO0.1.1

08/12/2023

15:38:23

212

142

BATE

00381639214TRLO0.1.1

08/12/2023

16:05:09

19

142

XLON

00381652417TRLO0.1.1

08/12/2023

16:13:43

387

141.4

BATE

00381657230TRLO0.1.1

08/12/2023

16:13:43

387

141.4

CHIX

00381657231TRLO0.1.1

08/12/2023

16:13:43

139

141.4

TRQX

00381657232TRLO0.1.1

08/12/2023

16:13:43

1161

141.4

XLON

00381657233TRLO0.1.1

08/12/2023

16:13:43

672

141.4

XLON

00381657234TRLO0.1.1

08/12/2023

16:13:43

102

141.4

XLON

00381657235TRLO0.1.1

08/12/2023

16:13:43

249

141.4

AQXE

00381657236TRLO0.1.1

08/12/2023

16:13:53

2620

141.8

XLON

00381657339TRLO0.1.1

08/12/2023

16:14:14

440

142

CHIX

00381657505TRLO0.1.1

08/12/2023

16:14:14

683

142

CHIX

00381657506TRLO0.1.1

08/12/2023

16:14:14

1586

142

CHIX

00381657507TRLO0.1.1

08/12/2023

16:15:13

61

142

XLON

00381658009TRLO0.1.1

08/12/2023

16:15:15

387

142

CHIX

00381658023TRLO0.1.1

08/12/2023

16:17:27

387

141.6

CHIX

00381659385TRLO0.1.1

08/12/2023

16:17:27

1548

141.6

XLON

00381659386TRLO0.1.1

08/12/2023

16:18:54

428

142

XLON

00381660203TRLO0.1.1

08/12/2023

16:18:54

19

142

XLON

00381660204TRLO0.1.1

08/12/2023

16:26:05

387

141.4

BATE

00381663621TRLO0.1.1

08/12/2023

16:26:05

387

141.4

CHIX

00381663622TRLO0.1.1

08/12/2023

16:29:43

1176

141.6

XLON

00381665210TRLO0.1.1

08/12/2023

16:29:44

791

141.6

XLON

00381665226TRLO0.1.1

08/12/2023

16:29:44

1214

141.6

XLON

00381665225TRLO0.1.1

08/12/2023

16:29:44

791

141.6

XLON

00381665227TRLO0.1.1

08/12/2023

16:29:44

289

141.6

XLON

00381665228TRLO0.1.1

08/12/2023

16:29:44

441

141.6

XLON

00381665229TRLO0.1.1

08/12/2023

16:29:45

763

141.6

XLON

00381665251TRLO0.1.1

08/12/2023

16:29:45

249

141.6

XLON

00381665252TRLO0.1.1

08/12/2023

16:29:46

648

141.6

XLON

00381665258TRLO0.1.1

08/12/2023

16:29:46

236

141.6

XLON

00381665259TRLO0.1.1

08/12/2023

16:29:46

101

141.6

XLON

00381665260TRLO0.1.1

08/12/2023

16:29:47

1345

141.6

XLON

00381665270TRLO0.1.1

08/12/2023

16:29:47

1261

141.6

XLON

00381665272TRLO0.1.1

08/12/2023

16:29:48

754

141.8

AQXE

00381665294TRLO0.1.1

08/12/2023

16:29:54

242

141.8

AQXE

00381665420TRLO0.1.1

08/12/2023

16:29:57

474

141.6

XLON

00381665492TRLO0.1.1

08/12/2023

16:29:57

787

141.6

XLON

00381665493TRLO0.1.1

08/12/2023

16:29:58

1261

141.6

XLON

00381665515TRLO0.1.1

08/12/2023

16:29:59

963

141.6

XLON

00381665525TRLO0.1.1

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSFLFETFVLTIIV
Date   Source Headline
21st Oct 20201:03 pmRNSAkili Presents New Data on EndeavorRx at AACAP
20th Oct 20201:08 pmRNSVor Appoints Biotech Leader Matt Patterson to BOD
12th Oct 20201:00 pmRNSNew Vedanta VE202 Data Presented at UEG Week
7th Oct 20201:03 pmRNSAkili Adds Award-Winning Marketing Leader as CMO
5th Oct 202012:00 pmRNSAlivio Awarded $3.3M from DoD to Advance ALV-304
1st Oct 20207:05 amRNSPureTech Appoints Biocon Founder Kiran Shaw to BOD
1st Oct 20207:00 amRNSTotal Voting Rights
30th Sep 20202:00 pmRNSBARDA Awards Vedanta Up to $76.9M to Advance VE303
29th Sep 202012:00 pmRNSAlivio Adds Dr Harry Leider to Board of Directors
25th Sep 20204:35 pmRNSPrice Monitoring Extension
23rd Sep 20207:00 amRNSPureTech Nasdaq Listing Progresses
18th Sep 20204:41 pmRNSSecond Price Monitoring Extn
18th Sep 20204:35 pmRNSPrice Monitoring Extension
18th Sep 202010:15 amRNSPrice Monitoring Extension
16th Sep 20201:00 pmRNSVedanta Appoints Drug Development Leader as CMO
4th Sep 202012:42 pmRNSGelesis Presents Plenity Efficacy and Safety Data
4th Sep 202012:07 pmRNSSecond Price Monitoring Extn
4th Sep 202012:02 pmRNSPrice Monitoring Extension
3rd Sep 202012:02 pmRNSPrice Monitoring Extension
28th Aug 20204:40 pmRNSSecond Price Monitoring Extn
28th Aug 20204:36 pmRNSPrice Monitoring Extension
27th Aug 20207:00 amRNSHalf-year Report
26th Aug 20201:02 pmRNSVor Appoints John King as Chief Commercial Officer
26th Aug 202012:40 pmRNSPRTC Receives $100M from Founded Entity Shares
26th Aug 202012:08 pmRNSPublication of Shareholder Circular
25th Aug 20202:05 pmRNSSonde Makes Acquisition in Vocal Biomarker Space
6th Aug 20207:00 amRNSNotice of Results
5th Aug 20207:00 amRNSPureTech to Present at Wedbush PacGrow Conference
3rd Aug 20207:00 amRNSTotal Voting Rights
30th Jul 20201:02 pmRNSVor Appoints Life Science Leader to BOD
30th Jul 202012:07 pmRNSSecond Price Monitoring Extn
30th Jul 202012:02 pmRNSPrice Monitoring Extension
21st Jul 202012:08 pmRNSSecond Price Monitoring Extn
21st Jul 202012:02 pmRNSPrice Monitoring Extension
17th Jul 20207:00 amRNSHolding(s) in Company
16th Jul 20201:04 pmRNSVor Appoints Biotech Finance Leader to BOD
14th Jul 20201:04 pmRNSVor Names Oncology Drug Development Expert as CMO
8th Jul 20201:32 pmRNSSonde Launches Voice Health Screening for COVID-19
8th Jul 202012:02 pmRNSPrice Monitoring Extension
7th Jul 202012:03 pmRNSPureTech’s Vor Raises $110M Series B Financing
6th Jul 20207:01 amRNSHolding(s) in Company
6th Jul 20207:00 amRNSHolding(s) in Company
1st Jul 20207:00 amRNSTotal Voting Rights
23rd Jun 20201:48 pmRNSKaruna Positive FDA End of Phase 2 Meeting
23rd Jun 20207:00 amRNSAkili Gets European Approval to Market EndeavorRx
22nd Jun 20202:00 pmRNSPRTC Presents New Immuno-oncology Data at AACR
22nd Jun 20207:00 amRNSPDMR Notification RSU Vesting
18th Jun 202012:01 pmRNSGelesis China Deal $35M and up to $388M milestones
16th Jun 20207:00 amRNSAkili Granted FDA Clearance for ADHD Treatment
15th Jun 202012:07 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.